Status:
UNKNOWN
Study of Preventive Treatment With Symbicort or Budicort Turbohaler in Childhood Asthma Return to School Epidemic
Lead Sponsor:
Meir Medical Center
Conditions:
Asthma Exacerbation
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
During the second week of September( week 38 of the year)there are recorded data of exacerbation of asthma all over the world, including Israel. A short preventive treatment of 6 weeks may reduce asth...
Detailed Description
During the second week of September( week 38 of the year)there are recorded data of exacerbation of asthma all over the world, including Israel. A short preventive treatment of 6 weeks may reduce asth...
Eligibility Criteria
Inclusion
- age : 6-18 years suffering from asthma asthma exacerbation during 1/9/2009-15/10/2009
- \-
Exclusion
- any chronic condition that can involve respiratory tract (other than asthma) treated as prevention with ICS or montelukast from July 2010 Treated with oral steroids during the August 2010 asthma exacerbation one week prior study inclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2012
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT01179152
Start Date
September 1 2010
End Date
October 1 2012
Last Update
March 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel